Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Study on the Relative Dose Intensity of PARP Inhibitors in Real-life on a Population of Patients Over 70 Years With Advanced Ovarian Cancer
This clinical study investigates real-world dosing of PARP inhibitors in patients over 70 with advanced ovarian cancer. Recruitment is curre…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 3]
A Phase 3 clinical trial is evaluating mirvetuximab soravtansine plus bevacizumab versus bevacizumab alone as maintenance therapy in platinu…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
A clinical trial update describing a real-world study on treatment experiences for breast, lung, ovarian cancer, multiple myeloma, and acute…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety and efficacy of a mesothelin-targeting logic-gated CAR T therapy in adults with solid tumors …
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies. [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 immunotherapy study for ovarian cancer and other advanced malignant solid tumors, sponsored…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents [Phase 1, Phase 2]
Clinical trial update on ascending doses of ceralasertib in combination with chemotherapy or other anti-cancer agents in advanced solid mali…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Identification of Genetic, Phenotypic, Clinical, Biological and Histological Factors Differentiating Patients With Ovarian Cancer Who Are Refractory to Platinum-based Therapy From Patients Defined as Long-term Responders to Platinum-based Therapy [NA]
A recruiting clinical trial aims to identify genetic, phenotypic, clinical, biological and histological factors that differentiate platinum-…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Menopausal Impact of Opportunistic Salpingectomy for Ovarian Cancer Prevention [NA]
A clinical trial from Umeå University investigates the menopausal effects of opportunistic salpingectomy for ovarian cancer prevention. The …
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer [Phase 1, Phase 2]
This clinical trial investigates intraperitoneal administration of TROP2 CAR-engineered IL-15-transduced cord blood–derived NK cells for tre…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
AZD5305 is being evaluated as a monotherapy and in combination with anti-cancer agents in a Phase 1/2 trial for multiple advanced solid mali…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors. [EARLY_Phase 1]
An early-phase, open-label, single-arm trial evaluating KT032 cell injections for safety, tolerability, pharmacokinetics, and preliminary ef…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy [NA]
A Dana-Farber Cancer Institute trial is exploring whether structured exercise can prevent immobility in patients with ovarian or endometrial…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors [Phase 1, Phase 2]
Clinical Trial Update on an ongoing Phase 1/2 study of allogeneic NK cells (EBNK-001) with low-dose interleukin-15, with or without pembroli…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update details a biomarker-guided allogeneic CAR-NK cell therapy using single-target or dual-target constructs for advan…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20) [Phase 1, Phase 2]
This trial investigates BI-1808 as a single agent and in combination with pembrolizumab (Keytruda) for advanced malignancies, including ovar…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Adavosertib With or Without Olaparib in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
This document provides a status update on a Phase 2 clinical trial evaluating adavosertib with or without olaparib for recurrent ovarian, fa…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302) [Phase 2]
A Phase 2 clinical trial evaluating tuvusertib in combination with niraparib or lartesertib in participants with epithelial ovarian cancer; …
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma [Phase 1]
Phase 1 clinical trial update for TNhYP218 anti-mesothelin CAR T cells in mesothelin-expressing solid tumors, including mesothelioma; recrui…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP) [NA]
A clinical trial update describing the Italian Tumor Chemogenomic Profiler (IT-TCP), an integrative multi-omics and functional platform to d…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: SOPHIE Trial: Surgery in Ovarian Cancer With PreHabilitation In ERAS [NA]
Update on the SOPHIE trial assessing surgery in advanced ovarian cancer with prehabilitation within an ERAS pathway; the study is currently …
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Hysterectomy and OPPortunistic SAlpingectomy [NA]
Göteborg University reports a clinical trial on hysterectomy with opportunistic salpingectomy for ovarian cancer complications; the study is…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation [Phase 1]
This clinical trial update states that CLSP-1025 is being evaluated in a Phase 1 study for adults with solid tumors harboring the p53 R175H …
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: First in Human Study of TORL-1-23 in Participants With Advanced Cancer [Phase 1]
TORL Biotherapeutics announced a first-in-human Phase 1 trial of TORL-1-23 for advanced cancers. The study is currently recruiting and inclu…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
This ClinicalTrials.gov entry describes a study by A2 Biotherapeutics evaluating HLA LOH analysis and apheresis for CAR-T cell manufacturing…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors [NA]
Clinical trial update on SY001, a mesothelin-targeting therapy, tested in a single-arm, dose-escalation study in subjects with advanced soli…